CClinicalTrials.gg
CompletedNCT04268641POSIT-HEMIUpdated Sep 19, 2024

Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients

An interventional study of Arm 1 and Arm 2 in Hemiplegia And/or Hemiparesis Following Stroke, sponsored by Hôpital NOVO. Completed at 7 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Hôpital NOVO · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The main purpose of this study is to assess the interest of using wheelchair positioning equipment on the decrease of postural disorders, compared to the standard use of a wheelchair

Read the detailed description

The stroke is the main cause of hemiplegia in developed countries. Fifteen percent of people who say they have a stroke need, at home, a wheelchair to get from one room to another. The use of a wheelchair can cause postural disorders which can lead to pain, orthopedic deformity and pressure ulcers.

This study aims to assess the interest of using wheelchair positioning equipment (Seat back, Positioning cushion and Belt) on the decrease of postural disorders.

This decrease will be assessed after a standardized course, performed under three different conditions: with the positioning equipment (Positioning cushion and Seat back), with the positioning equipment and the belt and with the wheelchair alone.

Clinical tool used to assess the decrease is the Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0).

This study, which will be the first prospective, interventional, multicenter, controlled and randomized study, could pave the way for guidelines of good practice, for wheelchair positioning of hemiplegic patients in France

02

Conditions studied

  • Hemiplegia And/or Hemiparesis Following Stroke

Keywords

  • Hemiplegia
  • Stroke
  • Wheelchair positioning
  • Propulsion
  • Pelvic posterior tilt
  • Obliquity
03

In context

Stroke

7,283 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's enrollment of 24 is below the median of 50 across 5,366 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Hôpital NOVO is the lead sponsor of 69 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Hemiplegic patient following a stroke
  • Hospitalized in a follow-up and rehabilitative care service, after hospital stays in a MCO service (neurology, neurosurgery or reanimation)
  • With a planned exit from hospital (homecoming, residential care facilities, nursing home, Long Term Care Unit ...)
  • Patient whose wheelchair choice should be already done
  • Patient who propels the wheelchair with the valid hand and/or valid foot
  • Written informed consent (IC) obtained
  • Patients with affiliation to the social security system

Exclusion criteria

Exclusion Criteria:

  • Good walk recovery (FAC scale >3)
  • Wheelchair with a double hand rim
  • Patient who cannot use his2 wheelchair independently
  • Cognitive disorders which prevent the ability to well understanding the instructions
  • Other pathology which can interfere with this protocol (Spinal disorder, morbid overweight (BMI>40...)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Use of positioning equipment order 1

    One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

    Other: Arm 1

  • Experimental
    Use of positioning equipment order 2

    One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

    Other: Arm 2

  • Experimental
    Use of positioning equipment order 3

    One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

    Other: Arm 3

  • Experimental
    Use of positioning equipment order 4

    One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

    Other: Arm 4

  • Experimental
    Use of positioning equipment order 5

    One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

    Other: Arm 5

  • Experimental
    Use of positioning equipment order 6

    One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

    Other: Arm 6

Interventions

  • OtherArm 1

    Materials used for the course : 1. : Standard Wheelchair 2. : Standard Wheelchair + Seat back + Positioning cushion 3. : Standard Wheelchair + Seat back + Positioning cushion + Belt

  • OtherArm 2

    Materials used for the course : 1. : Standard Wheelchair 2. : Standard Wheelchair + Seat back + Positioning cushion + Belt 3. : Standard Wheelchair + Seat back + Positioning cushion

  • OtherArm 3

    Materials used for the course : 1. : Standard Wheelchair + Seat back + Positioning cushion 2. : Standard Wheelchair + Seat back + Positioning cushion + Belt 3. : Standard Wheelchair

  • OtherArm 4

    Materials used for the course : 1. : Standard Wheelchair + Seat back + Positioning cushion 2. : Standard Wheelchair 3. : Standard Wheelchair + Seat back + Positioning cushion + Belt

  • OtherArm 5

    Materials used for the course : 1. : Standard Wheelchair + Seat back + Positioning cushion + Belt 2. : Standard Wheelchair 3. : Standard Wheelchair + Seat back + Positioning cushion

  • OtherArm 6

    Materials used for the course : 1. : Standard Wheelchair + Seat back + Positioning cushion + Belt 2. : Standard Wheelchair + Seat back + Positioning cushion 3. : Standard Wheelchair

06

What researchers measure

Primary outcomes

  1. Degree of pelvic posterior tilt

    The Primary Outcome Measure is the variation of the Degree of pelvic posterior tilt at the end of the three standardized course. These courses were performed with Standard Wheelchair, Standard Wheelchair + Seat back + Positioning cushion + Belt or with Standard Wheelchair + Seat back + Positioning cushion. The Degree of pelvic posterior tilt was measured using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)

    Time frame: Immediately after the end of the procedure, an average of 1 day

Secondary outcomes

  1. Variation of Degree of pelvic posterior tilt

    The variation of the Degree of pelvic posterior tilt was measured between the beginning and the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)

    Time frame: Baseline and immediately after the end of the procedure, an average of 1 day

  2. Variation of degree of lateral inclination of the torso

    The variation of the degree of lateral inclination of the torso was measured between the beginning and the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)

    Time frame: Baseline and immediately after the end of the procedure, an average of 1 day

  3. Variation of the degree of Pelvis obliquity

    The variation of the degree of Pelvis obliquity was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 =moderate and 3 = severe retroversion)

    Time frame: Baseline and immediately after the end of the procedure, an average of 1 day

  4. Degree of lateral inclination of the torso

    The degree of lateral inclination of the torso was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)

    Time frame: Immediately after the end of the procedure, an average of 1 day

  5. Degree of Pelvis obliquity

    The degree of Pelvis obliquity was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)

    Time frame: Immediately after the end of the procedure, an average of 1 day

  6. Measure of patient's satisfaction

    The satisfaction of patient was measured with a satisfaction questionnaire scale based on ease of movement, wheelchair comfort and pain during the course. For each item, patient ticks : Very satisfied, Satisfied, Neither satisfied or unsatisfied, Unsatisfied or Very unsatisfied

    Time frame: Immediately after the end of the procedure, an average of 1 day

  7. Ability to achieve the whole course

    Binary criteria (Yes / No)

    Time frame: Immediately after the end of the procedure, an average of 1 day

  8. Adverse event collect

    Total number of adverse event

    Time frame: Immediately after the end of the procedure, an average of 1 day

07

Study locations

7 sites
  • Groupement Hospitalier Intercommunal du Vexin
    Aincourt, 95510, France
  • Hôpital Raymond Poincaré
    Garche, 92380, France
  • Institut Régional de Réadaptation
    Lay-Saint-Christophe, 54690, France
  • Centre de l'ESPOIR
    Lille, 59260, France
  • Centre de Rééducation L'oiseau Blanc
    Mantes-la-Jolie, 78200, France
  • Centre de Rééducation et de Réadaptation Fonctionnelles
    Menucourt, 95180, France
  • Centre Hospitalier Universitaire de Toulouse
    Toulouse, 31059, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04268641
Lead sponsor
Hôpital NOVO
Responsible party
Sponsor
First posted
Feb 13, 2020
Start date
Aug 28, 2020
Primary completion
Dec 11, 2023
Completion
Dec 11, 2023
Last update
Sep 19, 2024

Study contacts

Nadine Pellegrini
principal investigator · Groupement Hospitalier Intercommunal du Vexin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion